Current Issue - July 2022, Volume 16, Issue No. 2

1. Al-Dujaili TM, Majer CN, Madhoun TE, Kassis SZ, Saleh AA. Deep venous thrombosis in spine surgery patients: incidence and hematoma formation. Int Surg. 2012; 97(2): 150-4. doi: 10.9738/CC71.1
2. Namboothiri S. Incidence of deep vein thrombosis after major spine surgeries with no mechanical or chemical prophylaxis. Evid Based Spine Care J. 2012; 3(3): 29-33. doi: 10.1055/s-0032-1327807
3. Kearon C, Akl EA, Comerota AJ, Prandoni P, Bounameaux H, Goldhaber SZ, et al. Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e419S-96. doi: 10.1378/chest.11-2301. Erratum in: Chest. 2012; 142(6): 1698- 704.
4. Gould MK, Garcia DA, Wren SM, Karanicolas PJ, Arcelus JI, Heit JA, et al. Prevention of VTE in nonorthopedic surgical patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest. 2012; 141(2 Suppl): e227S-77. doi: 10.1378/chest.11-2297. Erratum in: 2012; 141(5): 1369.
5. Holbrook A, Schulman S, Witt DM, Vandvik PO, Fish J, Kovacs MJ, et al. Evidence-based management of anticoagulant therapy: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. 2012; 141(2 Suppl): e152S-184. doi: 10.1378/chest.11-2295
6. Glotzbecker MP, Bono CM, Harris MB, Brick G, Heary RF, Wood KB. Surgeon practices regarding postoperative thromboembolic prophylaxis after high-risk spinal surgery. Spine (Phila Pa 1976). 2008; 33(26): 2915-21. doi: 10.1097/BRS.0b013e318190702a
7. Caprini JA, Arcelus JI, Maksimovic D, Glase CJ, Sarayba JG, Hathaway K. Thrombosis prophylaxis in orthopedic surgery: current clinical considerations. J South Orthop Assoc. 2002; 11(4): 190-6.
8. Colah RB, Mukherjee MB, Martin S, Ghosh K. Sickle cell disease in tribal populations in India. Indian J Med Res. 2015; 141(5): 509-15. doi: 10.4103/0971-5916.159492
9. Goldhaber SZ. Risk factors for venous thromboembolism. J Am Coll Cardiol. 2010; 56(1): 1-7. doi: 10.1016/j.jacc.2010.01.057
10. Goldhaber SZ. Venous thromboembolism: epidemiology and magnitude of the problem. Best Pract Res Clin Haematol. 2012; 25(3): 235-42. doi: 10.1016/j.beha.2012.06.007
11. Oda T, Fuji T, Kato Y, Fujita S, Kanemitsu N. Deep venous thrombosis after posterior spinal surgery. Spine (Phila Pa 1976). 2000; 25(22): 2962-7. doi: 10.1097/00007632-200011150-00019
12. Collins R, Scrimgeour A, Yusuf S, Peto R. Reduction in fatal pulmonary embolism and venous thrombosis by perioperative administration of subcutaneous heparin. Overview of results of randomized trials in general, orthopedic, and urologic surgery. N Engl J Med. 1988; 318(18): 1162-73. doi: 10.1056/NEJM198805053181805
13. Hamidi S, Riazi M. Cutoff values of plasma d-dimer level in patients with diagnosis of the venous thromboembolism after elective spinal surgery. Asian Spine J. 2015; 9(2): 232-8. doi: 10.4184/asj.2015.9.2.232
14. Cho JH, Kim JB, Lee DG. Correlation Between D-Dimer Level and Deep Venous Thrombosis in Patients With Acute Spinal Cord Injuries. Am J Phys Med Rehabil. 2020; 99(7): 613-6. doi: 10.1097/PHM.0000000000001383
15. Bono CM, Watters WC 3rd, Heggeness MH, Resnick DK, Shaffer WO, Baisden J, et al. An evidence-based clinical guideline for the use of antithrombotic therapies in spine surgery. Spine J. 2009; 9(12): 1046-51. doi: 10.1016/j.spinee.2009.09.005
16. Prevention of venous thrombosis and pulmonary embolism. NIH Consensus Development. 1986; 256(6): 744-9.
17. Cain JE Jr, Major MR, Lauerman WC, West JL, Wood KB, Fueredi GA. The morbidity of heparin therapy after development of pulmonary embolus in patients undergoing thoracolumbar or lumbar spinal fusion. Spine (Phila Pa 1976). 1995; 20(14): 1600- 3. doi: 10.1097/00007632-199507150-00008
18. Nanclares BVC, Padilla-Zambrano HS, El-Menyar A, Moscote-Salazar LR, Galwankar S, Pal R, et al. WACEM Consensus Paper 68 on Deep Venous Thrombosis after Traumatic Spinal Cord Injury. J Emerg Trauma Shock. 2019; 12(2): 150-4. doi: 10.4103/JETS.JETS_125_18
19. Tam DA. Protein C and protein S activity in sickle cell disease and stroke. J Child Neurol. 1997; 12(1): 19-21. doi: 10.1177/088307389701200103
20. Shabat S, Nyska A, Long PH, Goelman G, Abramovitch R, Ezov N, et al. Osteonecrosis in a chemically induced rat model of human hemolytic disorders associated with thrombosis--a new model for avascular necrosis of bone. Calcif Tissue Int. 2004; 74(3): 220-8. doi: 10.1007/s00223-003-0068-7
21. Villagra J, Shiva S, Hunter LA, Machado RF, Gladwin MT, Kato GJ. Platelet activation in patients with sickle disease, hemolysis- associated pulmonary hypertension, and nitric oxide scavenging by cell-free hemoglobin. 2007; 110(6): 2166-72. doi: 10.1182/blood-2006-12-061697
22. Ataga KI, Moore CG, Hillery CA, Jones S, Whinna HC, Strayhorn D, et al. Coagulation activation and inflammation in sickle cell disease-associated pulmonary hypertension. 2008; 93(1): 20-6. doi: 10.3324/haematol.11763
23. Naik RP, Streiff MB, Lanzkron S. Sickle cell disease and venous thromboembolism: what the anticoagulation expert needs to know. J Thromb Thrombolysis. 2013; 35(3): 352-8. doi: 10.1007/s11239-013-0895-y
24. Adjepong KO, Otegbeye F, Adjepong YA. Perioperative Management of Sickle Cell Disease. Mediterr J Hematol Infect Dis. 2018; 10(1): e2018032. doi: 10.4084/MJHID.2018.032

Abstract   |   Reference